ESR1 and breast carcinoma: Similarly, the parallel experiments on the estrogen-independent triple-negative MDA-MB-231 breast cancer cells showed that both metformin and rapamycin effectively inhibit cell growth, demonstrating the importance of ERα-independent ways in the realization of the cytostatic action of these drugs (Figure 6c).